Significantly, an assortment of two mAbs to HER2, pertuzumab and trastuzumab, in conjunction with chemotherapy, considerably prolonged progression-free survival of breast cancer patients whose tumors overexpress HER2 (8)

Significantly, an assortment of two mAbs to HER2, pertuzumab and trastuzumab, in conjunction with chemotherapy, considerably prolonged progression-free survival of breast cancer patients whose tumors overexpress HER2 (8). capability of…

Several small molecule kinase inhibitors with activity against FLT3 have been evaluated in patients with AML as solitary agents and in combination with rigorous chemotherapy, e

Several small molecule kinase inhibitors with activity against FLT3 have been evaluated in patients with AML as solitary agents and in combination with rigorous chemotherapy, e.g. restorative strategy for the…